Adenosine is a well-established pharmacological agent used in the management of various tachyarrhythmias, particularly supraventricular tachycardia (SVT). Its mechanism of action primarily involves the induction of transient atrioventricular (AV) block, which can effectively terminate certain types of tachycardia. However, its role in ventricular tachycardia (VT) is more nuanced and requires careful consideration of the underlying arrhythmia type.
In patients with broad complex tachycardia, the administration of adenosine can be diagnostically beneficial. It helps differentiate between SVT with aberrant conduction and VT. Typically, SVT will respond to adenosine, while VT will not, allowing clinicians to make informed decisions regarding further management (Ioannou, 2022; , Zauner et al., 2017). This diagnostic utility is crucial, as misdiagnosing VT as SVT can lead to inappropriate treatment strategies that may exacerbate the patient's condition (Matthews & Grace, 2020).
Moreover, there are specific cases where adenosine can convert certain forms of VT, particularly those that are adenosine-sensitive. For instance, studies have shown that patients with repetitive monomorphic VT may respond positively to adenosine, especially during rest when the arrhythmia is more likely to be triggered by vagal maneuvers (Lerman et al., 2014). This phenomenon underscores the importance of recognizing the arrhythmia's characteristics before administration. In some instances, adenosine has been reported to induce ventricular ectopy, which may lead to the reinitiation of re-entrant arrhythmias, thus complicating its use in patients with a history of VT (Rajkumar et al., 2017; , Kunnumpuram & Patel, 2012).
In pediatric populations, there is emerging evidence that adenosine may also be effective in certain types of VT, particularly those originating from the right ventricular outflow tract. In hemodynamically stable patients, adenosine, alongside vagal maneuvers, has demonstrated potential for conversion to sinus rhythm (Chaszczewski et al., 2018). However, caution is warranted, as the efficacy of adenosine can vary significantly based on the specific arrhythmic substrate and the patient's overall clinical condition (Collins et al., 2013).
In conclusion, while adenosine is primarily utilized for the treatment of SVT, its role in the management of VT is complex and context-dependent. Clinicians must carefully assess the type of tachycardia and the patient's hemodynamic stability before considering adenosine as a therapeutic option. The ability of adenosine to provide diagnostic clarity and potential therapeutic benefit in select cases of VT highlights its importance in the broader context of arrhythmia management.
References:
- Chaszczewski, K., Sosnowski, C., & Ganesan, R. (2018). Vagal termination of ventricular tachycardia in a pediatric patient. Pediatrics, 141(Supplement_5), S412-S415.
https://doi.org/10.1542/peds.2016-3792
- Collins, K., Schaffer, M., Liberman, L., Saarel, E., Knecht, M., Tanel, R., … & Triedman, J. (2013). Fascicular and nonfascicular left ventricular tachycardias in the young: an international multicenter study. Journal of Cardiovascular Electrophysiology, 24(6), 640-648.
https://doi.org/10.1111/jce.12105
- Ioannou, A. (2022). Atrial fibrillation with ventricular pre-excitation: a diagnosis that must not be missed. Archives of Medical Case Reports and Case Study, 5(4), 01-03.
https://doi.org/10.31579/2692-9392/106
- Kunnumpuram, G. and Patel, A. (2012). Adenosine-induced worsening of supraventricular tachycardia. BMJ Case Reports, bcr2012007821.
https://doi.org/10.1136/bcr-2012-007821
- Lerman, B., Ip, J., Shah, B., Thomas, G., Liu, C., Ciaccio, E., … & Markowitz, S. (2014). Mechanism‐specific effects of adenosine on ventricular tachycardia. Journal of Cardiovascular Electrophysiology, 25(12), 1350-1358.
https://doi.org/10.1111/jce.12510
- Matthews, G. and Grace, A. (2020). Unmasking adenosine: the purinergic signalling molecule critical to arrhythmia pathophysiology and management. Arrhythmia & Electrophysiology Review, 8(4), 240-248.
https://doi.org/10.15420/aer.2019.05
- Rajkumar, C., Qureshi, N., Ng, F., Panoulas, V., & Lim, P. (2017). Adenosine induced ventricular fibrillation in a structurally normal heart: a case report. Journal of Medical Case Reports, 11(1).
https://doi.org/10.1186/s13256-016-1177-z
- Zauner, F., Sieweke, J., Hohmann, S., Duncker, D., Riehle, C., Napp, L., … & Veltmann, C. (2017). One symptom, two arrhythmias: the rare and the even rarer. BMC Cardiovascular Disorders, 17(1).
https://doi.org/10.1186/s12872-017-0679-y